Generated by GPT-5-mini| Lithium-7 (Li-7) | |
|---|---|
| Name | Lithium-7 |
| Natural abundance | ~92.5% |
| Half life | Stable (observationally) |
Lithium-7 (Li-7) is a stable isotope of the chemical element lithium with three protons and four neutrons, constituting the majority of naturally occurring lithium. It plays a central role in cosmology, nuclear physics, and industrial applications, and its measured abundance provides constraints on models of the early universe and stellar evolution. Research on this isotope intersects with observational astronomy, particle physics, and geochemistry.
Lithium-7 appears prominently in studies involving Big Bang nucleosynthesis, solar physics, terrestrial geology, nuclear reactors, and pharmaceuticals. Its abundance and behavior are discussed in contexts ranging from work by teams at CERN and NASA to measurements by collaborations using facilities such as KEK and the European Southern Observatory. Prominent researchers and institutions—such as those at Princeton University, California Institute of Technology, Massachusetts Institute of Technology, Harvard University, Max Planck Society, and Lawrence Livermore National Laboratory—have contributed to its characterization.
The production of lithium-7 is a key prediction of Big Bang nucleosynthesis models tested against observations from surveys like Sloan Digital Sky Survey and instruments such as the Hubble Space Telescope and Planck. Predicted primordial 7Li from early-universe calculations was compared with stellar measurements by teams using the Very Large Telescope and Keck Observatory, informing debates exemplified in papers from groups at University of Cambridge, University of Tokyo, and University of Chicago. Stellar processes in asymptotic giant branch stars and novae, studied via observatories like ALMA and missions including Gaia, affect surface 7Li in stars examined by research at Observatoire de Paris and Max Planck Institute for Astrophysics. Discrepancies between predicted and observed 7Li—often termed the "lithium problem" in literature by authors at Yale University and University of California, Berkeley—have prompted investigations invoking particle physics scenarios explored at Fermilab and SLAC National Accelerator Laboratory.
As an isotope, 7Li exhibits nuclear structure properties explored through experiments at Brookhaven National Laboratory, Argonne National Laboratory, and TRIUMF. Nuclear magnetic resonance and scattering experiments performed at facilities such as ISIS Neutron and Muon Source and Oak Ridge National Laboratory probe its spin, binding energy, and excited states in collaborations including scientists from Stanford University and Imperial College London. The isotope's relative stability contrasts with short-lived isotopes studied at GSI Helmholtz Centre for Heavy Ion Research and theoretical models developed at Institute for Advanced Study and Los Alamos National Laboratory. Calculations from groups at Institute of Nuclear Physics PAN and Kavli Institute inform reaction rates used in astrophysical networks employed by researchers at University of Bonn and University of Barcelona.
Lithium-7 is central to technologies developed and deployed by organizations such as Tesla, Inc., Panasonic Corporation, and LG Chem in advanced rechargeable battery development; battery research at MIT Lincoln Laboratory and National Renewable Energy Laboratory often specifies isotopic compositions. Nuclear engineering projects at Électricité de France and Rosatom use 7Li-enriched compounds in molten salt reactors and tritium breeding studies conducted at ITER and JET (Joint European Torus). In medicine, 7Li chemistry informs pharmaceutical research at Pfizer and Roche and analytical standards used by hospitals associated with Mayo Clinic and Johns Hopkins Hospital. Isotopic tailoring for optical components, studied at Corning Inc. and Rutherford Appleton Laboratory, affects performance in telecommunications systems deployed by firms like AT&T and Verizon Communications.
Isotopic analysis of 7Li is routinely performed using mass spectrometry techniques developed at Thermo Fisher Scientific and utilized by laboratories at US Geological Survey, National Institute of Standards and Technology, and university facilities including University of Oxford. Methods include multi-collector inductively coupled plasma mass spectrometry used by researchers at ETH Zurich and University of Alberta, and secondary ion mass spectrometry applied in studies at Caltech and University of Washington. Nuclear magnetic resonance measurements at centers like Helmholtz Centre Berlin and Rutgers University provide complementary data; collaborators from Scripps Institution of Oceanography and Woods Hole Oceanographic Institution apply these techniques to geochemical cycling and oceanographic tracer studies.
Environmental monitoring and regulatory assessment involving lithium—work undertaken by agencies like the Environmental Protection Agency and European Environment Agency—consider isotopic composition when tracing contamination from mining operations by companies such as Albemarle Corporation and SQM. Health-related research at World Health Organization and clinical studies from institutions including Cleveland Clinic and University College London examine lithium pharmacology; although clinical lithium treatments typically involve natural isotopic mixtures, isotopic considerations have been discussed in toxicology studies at Centers for Disease Control and Prevention and National Institutes of Health. Geopolitical and economic aspects of lithium resources link to policymaking in regions represented by Government of Chile and Government of Australia where mining impacts assessed by United Nations Environment Programme and International Energy Agency intersect with scientific monitoring.
Category:Isotopes